Back to Results
First PageMeta Content
Medicine / Clopidogrel / Contraindication / Paliperidone / Rituximab / Osteoporosis / Diclofenac / Chemistry / Organic chemistry / Organochlorides


Appendix C Issued important risk information (DHPCs) in 2013 Date Brand name
Add to Reading List

Document Date: 2014-06-03 11:10:36

Open Document

File Size: 357,94 KB

Share Result on Facebook

Event

Product Recall / Product Issues / /

IndustryTerm

treatment of Kahler’s disease / /

MedicalCondition

capillary leak Neulasta pegfilgrastim syndrome / necrotising fasciitis / severe hypersensitivity / unstable angina / cancer / hypocalcemia / bradyarrhythmia / acquired haemophilia / essential thrombocythemia / hemophagocytic syndrome / Kahler’s disease / thrombosis / tumour / cataract / syndrome / toxic epidermal necrolysis / postmenopausal osteoporosis / /

MedicalTreatment

medication error / /

Product

clopidogrel / Xeloda / Vectibix / Neulasta / Plavix / ketoconazole / Risperidone / Pegintron / Invega / peginterferon / Avastin / Revlimid / ibuprofen / Neupogen / Vistide / Risperdal / Nujolix belatacept / Optimark / Nizoral / Increlex / Cilest ethinylestradiol/ / /

URL

www.cbgjaarverslag2013.nl / /

SocialTag